- Home
- NEO vs SDHC Comparison
NEO vs SDHC Comparison
Compare NEO & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- SDHC
- Stock Information
- Founded
- NEO 2001
- SDHC 2008
- Country
- NEO United States
- SDHC United States
- Employees
- NEO N/A
- SDHC N/A
- Industry
- NEO Precision Instruments
- SDHC
- Sector
- NEO Health Care
- SDHC
- Exchange
- NEO Nasdaq
- SDHC Nasdaq
- Market Cap
- NEO 963.9M
- SDHC 933.4M
- IPO Year
- NEO 1999
- SDHC 2024
- Fundamental
- Price
- NEO $5.10
- SDHC $19.34
- Analyst Decision
- NEO Buy
- SDHC Hold
- Analyst Count
- NEO 8
- SDHC 4
- Target Price
- NEO $12.14
- SDHC $23.63
- AVG Volume (30 Days)
- NEO 2.3M
- SDHC 67.8K
- Earning Date
- NEO 07-29-2025
- SDHC 08-06-2025
- Dividend Yield
- NEO N/A
- SDHC N/A
- EPS Growth
- NEO N/A
- SDHC N/A
- EPS
- NEO N/A
- SDHC 0.24
- Revenue
- NEO $689,189,000.00
- SDHC $1,010,976,000.00
- Revenue This Year
- NEO $13.83
- SDHC $3.34
- Revenue Next Year
- NEO $11.35
- SDHC $9.42
- P/E Ratio
- NEO N/A
- SDHC $80.99
- Revenue Growth
- NEO 9.70
- SDHC 28.67
- 52 Week Low
- NEO $4.81
- SDHC $16.28
- 52 Week High
- NEO $19.12
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- NEO 24.08
- SDHC 45.87
- Support Level
- NEO $4.81
- SDHC $20.00
- Resistance Level
- NEO $6.61
- SDHC $23.50
- Average True Range (ATR)
- NEO 0.37
- SDHC 1.09
- MACD
- NEO -0.15
- SDHC -0.12
- Stochastic Oscillator
- NEO 10.86
- SDHC 9.37
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.